174 related articles for article (PubMed ID: 25157876)
1. Resting heart rate is a risk factor for mortality in chronic obstructive pulmonary disease, but not for exacerbations or pneumonia.
Warnier MJ; Rutten FH; de Boer A; Hoes AW; De Bruin ML
PLoS One; 2014; 9(8):e105152. PubMed ID: 25157876
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study.
Çolak Y; Afzal S; Nordestgaard BG; Vestbo J; Lange P
Lancet Respir Med; 2017 May; 5(5):426-434. PubMed ID: 28389225
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies.
Schembri S; Williamson PA; Short PM; Singanayagam A; Akram A; Taylor J; Singanayagam A; Hill AT; Chalmers JD
BMJ; 2013 Mar; 346():f1235. PubMed ID: 23525864
[TBL] [Abstract][Full Text] [Related]
4. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
[TBL] [Abstract][Full Text] [Related]
5. Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia.
Sibila O; Mortensen EM; Anzueto A; Laserna E; Restrepo MI
Eur Respir J; 2014 Jan; 43(1):36-42. PubMed ID: 23598950
[TBL] [Abstract][Full Text] [Related]
6. U.K. National COPD Resources and Outcomes Project 2008: patients with chronic obstructive pulmonary disease exacerbations who present with radiological pneumonia have worse outcome compared to those with non-pneumonic chronic obstructive pulmonary disease exacerbations.
Myint PK; Lowe D; Stone RA; Buckingham RJ; Roberts CM
Respiration; 2011; 82(4):320-7. PubMed ID: 21597277
[TBL] [Abstract][Full Text] [Related]
7. Time-updated resting heart rate predicts mortality in patients with COPD.
Omlor AJ; Trudzinski FC; Alqudrah M; Seiler F; Biertz F; Vogelmeier CF; Welte T; Watz H; Waschki B; Brinker TJ; Andreas S; Fähndrich S; Alter P; Jörres RA; Böhm M; Bals R;
Clin Res Cardiol; 2020 Jun; 109(6):776-786. PubMed ID: 31734762
[TBL] [Abstract][Full Text] [Related]
8. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.
Raparelli V; Pastori D; Pignataro SF; Vestri AR; Pignatelli P; Cangemi R; Proietti M; Davì G; Hiatt WR; Lip GYH; Corazza GR; Perticone F; Violi F; Basili S;
Intern Emerg Med; 2018 Aug; 13(5):651-660. PubMed ID: 29582316
[TBL] [Abstract][Full Text] [Related]
9. COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months.
Sivapalan P; Ingebrigtsen TS; Rasmussen DB; Sørensen R; Rasmussen CM; Jensen CB; Allin KH; Eklöf J; Seersholm N; Vestbo J; Jensen JS
BMJ Open Respir Res; 2019; 6(1):e000407. PubMed ID: 31179005
[TBL] [Abstract][Full Text] [Related]
10. Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer.
Volpino P; Cangemi R; Fiori E; Cangemi B; De Cesare A; Corsi N; Di Cello T; Cangemi V
J Cardiovasc Surg (Torino); 2007 Jun; 48(3):375-83. PubMed ID: 17505444
[TBL] [Abstract][Full Text] [Related]
11. Right heart failure as a risk factor for severe exacerbation in patients with chronic obstructive pulmonary disease: Prospective cohort study.
Orea-Tejeda A; Navarrete-Peñaloza AG; Verdeja-Vendrell L; Jiménez-Cepeda A; González-Islas DG; Hernández-Zenteno R; Keirns-Davis C; Sánchez-Santillán R; Velazquez-Montero A; Puentes Rodríguez G
Clin Respir J; 2018 Dec; 12(12):2635-2641. PubMed ID: 30307708
[TBL] [Abstract][Full Text] [Related]
12. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
[TBL] [Abstract][Full Text] [Related]
13. Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia.
Søgaard M; Madsen M; Løkke A; Hilberg O; Sørensen HT; Thomsen RW
Int J Chron Obstruct Pulmon Dis; 2016; 11():455-65. PubMed ID: 27042038
[TBL] [Abstract][Full Text] [Related]
14. Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease.
Chen CZ; Ou CY; Yu CH; Yang SC; Chang HY; Hsiue TR
J Am Geriatr Soc; 2015 Feb; 63(2):244-50. PubMed ID: 25641518
[TBL] [Abstract][Full Text] [Related]
15. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.
Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Outcomes and All-Cause Mortality in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (Overlap Syndrome).
Kendzerska T; Leung RS; Aaron SD; Ayas N; Sandoz JS; Gershon AS
Ann Am Thorac Soc; 2019 Jan; 16(1):71-81. PubMed ID: 30372124
[TBL] [Abstract][Full Text] [Related]
17. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Teo E; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD010010. PubMed ID: 28626902
[TBL] [Abstract][Full Text] [Related]
18. Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD.
Fawzy A; Anderson JA; Cowans NJ; Crim C; Wise R; Yates JC; Hansel NN
Respir Res; 2019 May; 20(1):86. PubMed ID: 31068182
[TBL] [Abstract][Full Text] [Related]
19. Impact of Frailty on the Risk of Exacerbations and All-Cause Mortality in Elderly Patients with Stable Chronic Obstructive Pulmonary Disease.
Luo J; Zhang D; Tang W; Dou LY; Sun Y
Clin Interv Aging; 2021; 16():593-601. PubMed ID: 33880018
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.
Walters JA; Tang JN; Poole P; Wood-Baker R
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD001390. PubMed ID: 28116747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
